Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Triebel

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
A hsp70-2 mutation recognized by CTL on a human renal cell carcinomaC Gaudin, F Kremer, E Angevin, et al.
European Cytokine Network|May 1, 1990
The gamma/delta T cell receptor expressed on human peripheral blood lymphocytesF Faure, C Miossec, S Jitsukawa, et al.
Immunogenetics|January 1, 1994
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligandB Huard, P Gaulard, F Faure, et al.
Molecular Immunology|February 1, 1994
TCR gene segments from at least one third of V alpha subfamilies rearrange at the delta locusC Genevée, V Chung, A Diu, et al.
The Journal of Experimental Medicine|October 1, 1987
A novel subset of human lymphocytes with a T cell receptor-gamma complexS Jitsukawa, F Faure, M Lipinski, et al.
Leukemia Research|January 1, 1979
The selective removal of red blood cells from bone marrow cell suspensionsF Triebel, B Rio, J Tanzer, et al.
International Journal of Cancer|July 29, 1997
Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicityE Angevin, F Kremer, C Gaudin, et al.
European Journal of Immunology|September 1, 1995
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteinsB Huard, P Prigent, M Tournier, et al.
European Journal of Immunology|December 1, 1994
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytesB Huard, M Tournier, T Hercend, et al.
International Journal of Cancer|December 15, 1994
The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administrationF Farace, E Angevin, J Vanderplancke, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
A hsp70-2 mutation recognized by CTL on a human renal cell carcinomaC Gaudin, F Kremer, E Angevin, et al.
European Cytokine Network|May 1, 1990
The gamma/delta T cell receptor expressed on human peripheral blood lymphocytesF Faure, C Miossec, S Jitsukawa, et al.
Immunogenetics|January 1, 1994
Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligandB Huard, P Gaulard, F Faure, et al.
Molecular Immunology|February 1, 1994
TCR gene segments from at least one third of V alpha subfamilies rearrange at the delta locusC Genevée, V Chung, A Diu, et al.
The Journal of Experimental Medicine|October 1, 1987
A novel subset of human lymphocytes with a T cell receptor-gamma complexS Jitsukawa, F Faure, M Lipinski, et al.
Leukemia Research|January 1, 1979
The selective removal of red blood cells from bone marrow cell suspensionsF Triebel, B Rio, J Tanzer, et al.
International Journal of Cancer|July 29, 1997
Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicityE Angevin, F Kremer, C Gaudin, et al.
European Journal of Immunology|September 1, 1995
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteinsB Huard, P Prigent, M Tournier, et al.
European Journal of Immunology|December 1, 1994
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytesB Huard, M Tournier, T Hercend, et al.
International Journal of Cancer|December 15, 1994
The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administrationF Farace, E Angevin, J Vanderplancke, et al.
Pageof 12